Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lynne S. Newbold"'
Autor:
Shamez N. Ladhani, Jay Lucidarme, Lynne S. Newbold, Stephen J. Gray, Anthony D. Carr, Jamie Findlow, Mary E. Ramsay, Edward B. Kaczmarski, Raymond Borrow
Publikováno v:
Emerging Infectious Diseases, Vol 18, Iss 1, Pp 63-70 (2012)
Enhanced national surveillance for invasive meningococcal disease in England and Wales identified an increase in laboratory-confirmed capsular group Y (MenY) disease from 34 cases in 2007 to 44 in 2008 and 65 in 2009. For cases diagnosed in 2009, pat
Externí odkaz:
https://doaj.org/article/22ff0c0db402489ea07e049d3622d986
Autor:
Aiswarya Lekshmi, Annaliesa S. Anderson, Jay Lucidarme, Ray Borrow, Kathrin U. Jansen, Stephen Clark, Lynne S. Newbold, Li Hao, How Tsao, Lisa Lee-Jones
Publikováno v:
Journal of Infection. 73:63-70
Summary Objectives To compare the distribution of capsular groups and factor H-binding protein (fHBP) variants among meningococcal isolates and non-culture clinical specimens and to assess the representativeness of group B isolates amongst group B ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::519817f020bec95fce86b6b1d1b52d7f
https://doi.org/10.1016/j.jinf.2016.03.012
https://doi.org/10.1016/j.jinf.2016.03.012
Autor:
Ray Borrow, Lynne S. Newbold, Julia S. Bennett, Jamie Findlow, Martin C. J. Maiden, Jay Lucidarme, Lynne Richardson, Stefanie Gilchrist, Edward B. Kaczmarski, Stephen J. Gray
Publikováno v:
Clinical and Vaccine Immunology. 20:1360-1369
The poor immunogenicity of the meningococcal serogroup B (MenB) capsule has led to the development of vaccines targeting subcapsular antigens, in particular the immunodominant and diverse outer membrane porin, PorA. These vaccines are largely strain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c44608a8e4e55de6ca8d6b12c2c38845
https://doi.org/10.1128/cvi.00090-13
https://doi.org/10.1128/cvi.00090-13
Autor:
Ray Borrow, Mary Ramsay, Laura Serino, Jay Lucidarme, Maria Stella, Stephanie Slater, Stephen Clark, Lynne S. Newbold, Maria Giuliani, Sydel R. Parikh, Stephen J. Gray, Jamie Findlow, Rosita De Paola, Shamez N Ladhani, Mariagrazia Pizza, Monica Moschioni
Publikováno v:
The Lancet. Infectious diseases. 17(7)
Summary Background The UK introduced 4CMenB—a multicomponent vaccine against serogroup B meningococcal disease—into the national infant immunisation programme in September, 2015. The Meningococcal Antigen Typing System (MATS) was used to estimate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6224848b85409bc479a93edc5e89a014
https://pubmed.ncbi.nlm.nih.gov/28366724
https://pubmed.ncbi.nlm.nih.gov/28366724
Autor:
Malcolm Guiver, Shamez N Ladhani, Lynne S. Newbold, Helen Campbell, Jessica Flood, Richard H. Mallard, Ray Borrow, Stephen J. Gray, Edward B. Kaczmarski, Mary Ramsay
Publikováno v:
Vaccine. 30:3710-3716
A number of meningococcal vaccines have either been recently licensed or are in late-phase clinical trials. To inform national vaccination policy, it is important to define the burden of disease and the potential impact of any new vaccine. This study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9d3e72c1041632b09785479824e36b1
https://doi.org/10.1016/j.vaccine.2012.03.011
https://doi.org/10.1016/j.vaccine.2012.03.011
Autor:
Patrick S. L. Kwan, Andrew J. Fox, Andrew Birtles, Nigel P. French, F. J. Bolton, Lynne S. Newbold, Susan E. Robinson, Mathew Upton
Publikováno v:
Applied and Environmental Microbiology. 74:3626-3633
Multilocus sequence typing (MLST), an accurate and phylogenetically robust characterization method for population studies of Campylobacter , was applied to Campylobacter jejuni isolates ( n = 297) from the fecal samples of cattle from five dairy farm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be2ce5fad9afe567accdc80041d7ff0f
https://doi.org/10.1128/aem.01669-07
https://doi.org/10.1128/aem.01669-07
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89921 (2014)
PLoS ONE
PLoS ONE
Factor H-Binding Protein (fHbp) is an outer membrane protein antigen included in two novel meningococcal group B vaccines and, as such, is an important typing target. Approximately 50% of meningococcal disease cases in England and Wales are confirmed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::595aad2400c4b3c95ce7547ff0406e18
http://europepmc.org/articles/PMC3933679?pdf=render
http://europepmc.org/articles/PMC3933679?pdf=render
Autor:
Jay Lucidarme, Lynne S. Newbold, Anthony D. Carr, Jamie Findlow, James Hewitt, Stefanie Gilchrist, Ray Borrow, Edward B. Kaczmarski, Stephen J. Gray
In 2007, recommendations were proposed for the molecular typing of meningococci. Multilocus sequence typing (MLST) was recommended to guide national and international disease management and facilitate studies of population biology and evolution. Sequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb33b9a51e5b42eae4d06cab7ee3114a
https://europepmc.org/articles/PMC3067353/
https://europepmc.org/articles/PMC3067353/
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89921 (2014)
Factor H-Binding Protein (fHbp) is an outer membrane protein antigen included in two novel meningococcal group B vaccines and, as such, is an important typing target. Approximately 50% of meningococcal disease cases in England and Wales are confirmed
Externí odkaz:
https://doaj.org/article/32bd460f8cb84a15b63a051047ff55f8